MRD සහ CAR T-Cell චිකිත්සාව අතර සබඳතා අවබෝධ කර ගැනීම
What is MRD in cancer treatment? Measurable Residual Disease, or MRD, is the name for the very few cancer cells that stay in the body after or during treatment. Flow cytometry, polymerase chain reaction (PCR), or next-generati..
ස්නායු ආබාධ වලදී Mesenchymal ප්රාථමික සෛල චිකිත්සාව
Neurological diseases are big problems around the world because they cause a lot of death and disability. Traditional treatments haven't always worked, which has led to a change toward new methods like cell-based therapies. Beca..
මහා බඩවැලේ පිළිකා සඳහා ප්රතිකාර කිරීම සඳහා FDA විසින් CART T-Cell Therapy A2B530 වෙත අනාථ ඖෂධ නාමය ලබා දී ඇත.
In March 2024, a news release said that A2B530 (A2 Biotherapeutics), a CAR T-cell therapy, had been given Orphan Drug Designation to treat colorectal cancer that expresses carcinoembryonic antigen (CEA) and has lost HLA-A*02 expr..
Iovance's Amtagvi USFDA විසින් ඝන ගෙඩියක් සඳහා පළමු T-සෛල චිකිත්සාව ලෙස අනුමත කර ඇත
Iovance Biotherapeutics' first-of-its-kind immunotherapy was approved by the FDA. This means that T-cell therapy, which has changed the way some types of blood cancer are treated, can now be used directly on solid tumors.The drug..
Amivantamab-vmjw USFDA විසින් EGFR exon 20 ඇතුළත් කිරීම-විකෘති නොවන කුඩා සෛල පෙනහළු පිළිකා ඇඟවීම් සඳහා අනුමත කර ඇත.
The Food and Drug Administration approved amivantamab-vmjw (Rybrevant, Janssen Biotech, Inc.) in combination with carboplatin and pemetrexed on March 1, 2024. Patients with epidermal growth factor receptor (EGFR) exon 20 insertio..
EGFR-විකෘති නොවන කුඩා සෛල පෙනහළු පිළිකා සඳහා රසායනික චිකිත්සාව සමඟ Osimertinib USFDA විසින් අනුමත කර ඇත.
The Food and Drug Administration approved osimertinib (Tagrisso, AstraZeneca Pharmaceuticals LP) in combination with platinum-based chemotherapy for patients with locally advanced or metastatic non-small cell lung cancer (la/mNSC..
Lifileucel හඳුනා ගත නොහැකි හෝ metastatic melanoma සඳහා USFDA විසින් අනුමත කර ඇත
The Food and Drug Administration granted accelerated approval to lifileucel (Amtagvi, Iovance Biotherapeutics, Inc.) on February 16, 2024. This approval is for adult patients with unresectable or metastatic melanoma who have been..
කුඩා නොවන සෛල පෙනහළු පිළිකා සඳහා Tepotinib USFDA විසින් අනුමත කර ඇත
The Food and Drug Administration officially approved tepotinib (Tepmetko, EMD Serono, Inc.) on February 15, 2024, for adult patients with metastatic non-small cell lung cancer (NSCLC) that had mesenchymal-epithelial transition (M..
Irinotecan liposome metastatic pancreatic adenocarcinoma හි පළමු පෙළ ප්රතිකාර සඳහා USFDA විසින් අනුමත කර ඇත.
The Food and Drug Administration approved irinotecan liposome (Onivyde, Ipsen Biopharmaceuticals, Inc.) with oxaliplatin, fluorouracil, and leucovorin on February 13, 2024, for treating metastatic pancreatic adenocarcinoma as the..
Erdafitinib දේශීයව උසස් හෝ metastatic urothelial පිළිකා සඳහා USFDA විසින් අනුමත කර ඇත.
Erdafitinib (Balversa, Janssen Biotech) was approved by the Food and Drug Administration on January 19, 2024, for adult patients with FGFR3 genetic changes who have locally advanced or metastatic urothelial carcinoma (mUC). Patie..